Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: January 17, 2006
Last updated: September 22, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2006
  Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):